We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+11.96%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$109B
AUM Growth
+$5.89B
(+5.7%)
Cap. Flow
-$3.72B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
32.97%
Holding
343
New
8
Increased
53
Reduced
229
Closed
9
Avg Time Held
5.7
years
Top 10 Avg Time Held
5
years
Top 20 Avg Time Held
5.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Splunk Inc
SPLK
|
+$164M |
| 2 |
Fidelity National Information Services
FIS
|
+$140M |
| 3 |
Intel
INTC
|
+$124M |
| 4 |
GSK
GSK
|
+$111M |
| 5 |
Mobileye
MBLY
|
+$62.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$753M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$370M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Charles Schwab
SCHW
|
+$197M |
| 5 |
Morgan Stanley
MS
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.81% |
| 2 | Technology | 27.17% |
| 3 | Industrials | 11.89% |
| 4 | Financials | 8.82% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
76
Morgan Stanley
MS
$286B
| $302M | 0.28% |
3,551,743
-1,697,218
| -32% | -$145M |
2020 Q4
8 quarters
|
|
77
Corning
GLW
$119B
| $291M | 0.27% |
9,113,919
-122,600
| -1% | -$3.98M |
2013 Q2
38 quarters
|
|
78
MarketAxess Holdings
MKTX
$5.79B
| $274M | 0.25% |
982,030
+18,150
| +2% | +$4.67M |
2013 Q2
38 quarters
|
|
79
CME Group
CME
$104B
| $273M | 0.25% |
1,620,930
+111,300
| +7% | +$19.3M |
2013 Q2
38 quarters
|
|
80
Trimble
TRMB
$14.2B
| $264M | 0.24% |
5,225,046
-323,940
| -6% | -$18M |
2013 Q2
38 quarters
|
|
81
Apple
AAPL
$4.99T
| $259M | 0.24% |
1,991,800
-96,000
| -5% | -$13.7M |
2013 Q2
38 quarters
|
|
82
LivaNova
LIVN
$4.32B
| $255M | 0.23% |
4,594,917
+18,227
| +0.4% | +$931K |
2018 Q4
16 quarters
|
|
83
Jabil
JBL
$30.1B
| $244M | 0.22% |
3,583,600
-135,000
| -4% | -$8.92M |
2013 Q2
38 quarters
|
|
84
Bath & Body Works
BBWI
$4.12B
| $243M | 0.22% |
5,778,265
-109,705
| -2% | -$4.09M |
2013 Q2
38 quarters
|
|
85
Insulet
PODD
$9.62B
| $241M | 0.22% |
818,508
-356,102
| -30% | -$98.2M |
2013 Q2
38 quarters
|
|
86
General Dynamics
GD
$91.2B
| $236M | 0.22% |
950,650
-15,930
| -2% | -$3.89M |
2016 Q4
24 quarters
|
|
87
DELISTED
Discover Financial Services
DFS
| $228M | 0.21% |
2,329,879
-625,640
| -21% | -$63M |
2014 Q1
35 quarters
|
|
88
Universal Display
OLED
$3.6B
| $226M | 0.21% |
2,088,849
-48,350
| -2% | -$5.07M |
2014 Q3
33 quarters
|
|
|
89
Charles Schwab
SCHW
$163B
| $226M | 0.21% |
2,708,942
-2,544,294
| -48% | -$197M |
2013 Q2
38 quarters
|
|
|
90
Fidelity National Information Services
FIS
$18.6B
| $224M | 0.2% |
3,297,050
+1,973,850
| +149% | +$140M |
2021 Q1
7 quarters
|
|
91
Kyntra Bio
KYNB
$21.7M
| $223M | 0.2% |
555,803
+28,607
| +5% | +$11M |
2019 Q4
12 quarters
|
|
92
Goldman Sachs
GS
$260B
| $217M | 0.2% |
631,750
-3,400
| -0.5% | -$1.18M |
2020 Q4
8 quarters
|
|
93
Descartes Systems
DSGX
$7.58B
| $214M | 0.2% |
3,078,806
-384,300
| -11% | -$26.3M |
2013 Q2
38 quarters
|
|
94
Dollar Tree
DLTR
$23.3B
| $214M | 0.2% |
1,512,815
-29,200
| -2% | -$4.35M |
2020 Q2
10 quarters
|
|
95
Transocean
RIG
$6.15B
| $212M | 0.19% |
46,564,489
-388,617
| -0.8% | -$1.5M |
2013 Q2
38 quarters
|
|
96
Capri Holdings
CPRI
$1.8B
| $202M | 0.18% |
3,522,675
-38,950
| -1% | -$1.97M |
2018 Q2
18 quarters
|
|
97
Rhythm Pharmaceuticals
RYTM
$6.06B
| $201M | 0.18% |
6,911,142
-115,750
| -2% | -$2.97M |
2019 Q3
13 quarters
|
|
98
Carrier Global
CARR
$45.3B
| $200M | 0.18% |
4,849,272
-59,900
| -1% | -$2.43M |
2020 Q2
10 quarters
|
|
99
Progressive
PGR
$124B
| $198M | 0.18% |
1,525,000
-40,550
| -3% | -$5.14M |
2014 Q3
33 quarters
|
|
100
Entegris
ENTG
$22.4B
| $197M | 0.18% |
3,003,644
-6,468
| -0.2% | -$476K |
2013 Q2
38 quarters
|
|
Similar funds
Primecap Management's Q4 2022 Portfolio in Review
As of Q4 2022, Primecap Management held 343 positions worth $109B, up 5.7% from $103B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management withdrew a net $3.72B in Q4 2022, closing 9 positions and reducing 229 holdings. Its most notable exit was Abiomed Inc, an estimated $370M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Mobileye worth $72.3M.
- Primecap Management's largest Q4 2022 buy was Mobileye: 2,061,470 shares worth $72.3M.
- Primecap Management added most to Splunk Inc in Q4 2022, an estimated $164M increase.
- Primecap Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $753M.
- Primecap Management fully exited Abiomed Inc in Q4 2022, selling an estimated $370M.
- Primecap Management's ten largest holdings make up 33% of its $109B portfolio in Q4 2022.
- Primecap Management opened 8 new positions and closed 9 in Q4 2022.
- Primecap Management's portfolio value rose 5.7% quarter-over-quarter to $109B.
Based on Primecap Management's 13F filing for Q4 2022, filed 13 Feb 2023.